Insider Stock Trading History of Aasen Thomas H


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Aasen Thomas H since year 2005. The trader's CIK number is 1291969. At the time of this reporting, Aasen Thomas H is the Vice Pres., CFO, Tre of Acadia Pharmaceuticals Inc . (stock ticker symbol ACAD). See this page for all insider trading activities at Acadia Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Aasen Thomas H since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-04-04 ACAD Acadia Pharmaceuticals Inc Option Ex 7,500 1.55 11,625
2014-04-04 ACAD Acadia Pharmaceuticals Inc Sale 15,000 22.48 337,260
2014-01-02 ACAD Acadia Pharmaceuticals Inc Option Ex 22,000 1.55 34,100
2014-01-02 ACAD Acadia Pharmaceuticals Inc Sale 30,000 24.88 746,340
2013-12-12 ACAD Acadia Pharmaceuticals Inc Option Ex 12,000 4.25 51,000
2013-10-01 ACAD Acadia Pharmaceuticals Inc Option Ex 22,500 4.25 95,625
2013-10-01 ACAD Acadia Pharmaceuticals Inc Sale 30,000 27.87 836,130
2013-08-13 ACAD Acadia Pharmaceuticals Inc Sale 60,000 20.15 1,209,180
2013-08-13 ACAD Acadia Pharmaceuticals Inc Option Ex 45,000 1.55 69,750
2013-04-11 ACAD Acadia Pharmaceuticals Inc Option Ex 34,029 1.54 52,506
2013-04-11 ACAD Acadia Pharmaceuticals Inc Sale 40,000 11.06 442,400
2013-04-01 ACAD Acadia Pharmaceuticals Inc Option Ex 40,000 1.08 43,200
2013-04-01 ACAD Acadia Pharmaceuticals Inc Sale 40,000 7.68 307,080
2013-01-17 ACAD Acadia Pharmaceuticals Inc Option Ex 12,000 1.08 12,960
2012-11-27 ACAD Acadia Pharmaceuticals Inc Sale 30,900 6.24 192,846
2012-11-28 ACAD Acadia Pharmaceuticals Inc Sale 9,100 5.25 47,775
2012-11-28 ACAD Acadia Pharmaceuticals Inc Option Ex 5,000 1.08 5,400
2012-09-07 ACAD Acadia Pharmaceuticals Inc Option Ex 7,500 1.50 11,250
2012-08-03 ACAD Acadia Pharmaceuticals Inc Option Ex 5,000 1.50 7,500
2008-02-13 ACAD Acadia Pharmaceuticals Inc Sale 8,000 10.86 86,904
2008-02-13 ACAD Acadia Pharmaceuticals Inc Option Ex 8,000 1.08 8,640
2008-02-14 ACAD Acadia Pharmaceuticals Inc Option Ex 5,000 1.08 5,400
2007-12-06 ACAD Acadia Pharmaceuticals Inc Option Ex 4,000 1.08 4,320
2007-12-07 ACAD Acadia Pharmaceuticals Inc Option Ex 2,000 1.08 2,160
2007-12-06 ACAD Acadia Pharmaceuticals Inc Sale 4,000 12.02 48,100
2007-11-14 ACAD Acadia Pharmaceuticals Inc Sale 8,000 11.22 89,736
2007-11-15 ACAD Acadia Pharmaceuticals Inc Option Ex 5,000 1.08 5,400
2007-08-15 ACAD Acadia Pharmaceuticals Inc Sale 16,000 15.56 248,896
2006-08-24 ACAD Acadia Pharmaceuticals Inc Sale 8,000 8.00 64,000
2006-08-24 ACAD Acadia Pharmaceuticals Inc Option Ex 4,000 .00 0
2006-05-18 ACAD Acadia Pharmaceuticals Inc Sale 8,000 10.67 85,360
2006-05-18 ACAD Acadia Pharmaceuticals Inc Sale 8,000 10.67 85,360
2006-02-15 ACAD Acadia Pharmaceuticals Inc Sale 12,000 15.10 181,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Aasen Thomas H (Vice Pres., CFO, Tre of Acadia Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.